These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7135889)
1. Build-up maintenance of IgG serum concentrations with intravenous immunoglobulin in patients with primary humoral immunodeficiency. Morell A; Schnoz M; Barandun S Vox Sang; 1982; 43(4):212-9. PubMed ID: 7135889 [TBL] [Abstract][Full Text] [Related]
2. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Ochs HD; Fischer SH; Wedgwood RJ; Wara DW; Cowan MJ; Ammann AJ; Saxon A; Budinger MD; Allred RU; Rousell RH Am J Med; 1984 Mar; 76(3A):78-82. PubMed ID: 6424461 [TBL] [Abstract][Full Text] [Related]
3. Increased half-life of gammaglobulin after prolonged intravenous replacement therapy. Lever AM; Yap PL; Cuthbertson B; Wootton R; Webster AD Clin Exp Immunol; 1987 Feb; 67(2):441-6. PubMed ID: 3038439 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency. Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J; Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015 [TBL] [Abstract][Full Text] [Related]
5. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Montanaro A; Pirofsky B Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459 [TBL] [Abstract][Full Text] [Related]
6. Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies. Shirani KZ; Vaughan GM; McManus AT; Amy BW; McManus WF; Pruitt BA; Mason AD Am J Med; 1984 Mar; 76(3A):175-80. PubMed ID: 6424447 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Pirofsky B Am J Med; 1984 Mar; 76(3A):53-60. PubMed ID: 6424457 [TBL] [Abstract][Full Text] [Related]
8. Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies. Gustafson R; Gardulf A; Hansen S; Leibl H; Engl W; Lindén M; Müller A; Hammarström L Clin Exp Immunol; 2008 May; 152(2):274-9. PubMed ID: 18341618 [TBL] [Abstract][Full Text] [Related]
9. [Intravenous immunoglobulin administration for antibody deficiency (author's transl)]. Luthardt T Dtsch Med Wochenschr; 1980 Jul; 105(28):993-7. PubMed ID: 7408694 [TBL] [Abstract][Full Text] [Related]
10. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage. Schiff RI; Rudd C; Johnson R; Buckley RH Clin Immunol Immunopathol; 1984 Apr; 31(1):13-23. PubMed ID: 6421523 [TBL] [Abstract][Full Text] [Related]
11. Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases. Fischer SH; Ochs HD; Wedgwood RJ; Skvaril F; Morell A; Hill HR; Schiffmann G; Corey L Monogr Allergy; 1988; 23():225-35. PubMed ID: 3386642 [TBL] [Abstract][Full Text] [Related]
12. Phase I study of intravenous gamma globulin in multiple myeloma. Gordon DS; Hearn EB; Spira TJ; Reimer CB; Phillips DJ; Schable C Am J Med; 1984 Mar; 76(3A):111-6. PubMed ID: 6424442 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin substitution therapy in a patient with primary hypogammaglobulinaemia and anti-IgA antibodies. Hedderich U; Kratzsch G; Stephen W; Dichtelmüller H; Olischläger K; Heimpel H Clin Allergy; 1986 Jul; 16(4):339-44. PubMed ID: 3488850 [TBL] [Abstract][Full Text] [Related]
15. [Intravenous administration of plasmin-treated immunoglobulins. A 2-year study in 16 patients with humoral deficiency]. Luzi G; Rosei L; d'Offizi GP Presse Med; 1983 Nov; 12(41):2631-3. PubMed ID: 6228804 [TBL] [Abstract][Full Text] [Related]
16. High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. Berger M; Cupps TR; Fauci AS JAMA; 1982 May; 247(20):2824-5. PubMed ID: 7077789 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of treatment of children with hypogammaglobulinemia: comparison of fresh plasma and intravenous immunoglobulin preparation. Bernatowska E; Weremowicz R; Janowicz W; Madaliński K Arch Immunol Ther Exp (Warsz); 1986; 34(4):377-84. PubMed ID: 3099724 [TBL] [Abstract][Full Text] [Related]
18. Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia. Björkander J; Nikoskelainen J; Leibl H; Lanbeck P; Wallvik J; Lumio JT; Braconier JH; Pavlova BG; Birthistle K; Engl W; Walter S; Ehrlich HJ Vox Sang; 2006 May; 90(4):286-93. PubMed ID: 16635071 [TBL] [Abstract][Full Text] [Related]
19. A comparison of native and modified intravenous immunoglobulin for the management of hypogammaglobulinemia. Steele RW; Augustine RA; Steele RW; Tannenbaum AS; Charlton RK Am J Med Sci; 1987 Feb; 293(2):69-74. PubMed ID: 3565455 [TBL] [Abstract][Full Text] [Related]
20. Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia. Roifman CM; Gelfand EW Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S92-6. PubMed ID: 3399285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]